Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care
{{output}}
The advent of effective immunotherapy, specifically cytotoxic T-lymphocyte associated protein 4 and programmed cell death 1 inhibitors, as well as targeted therapy including BRAF/MEK inhibitors, has dramatically changed the prognosis for metastatic melanoma pa... ...